Search
Indinavir
go.drugbank.com/drugs/DB00224ApprovedInvestigationalA potent and specific HIV protease inhibitor that appears to have good oral bioavailability. [PubChem]
Synonyms: (1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-pentonamideTalbutal
go.drugbank.com/drugs/DB00306ApprovedIllicitTalbutal, also called 5-allyl-5-sec-butylbarbituric acid, is a barbiturate with a short to intermediate duration of action. Talbutal is a schedule III drug in the U.S.
mRNA-3927
go.drugbank.com/drugs/DB17669InvestigationalDeveloped by Moderna Inc., it is being investigated for the treatment of propionic acidemia.[L45998]
Pimagedine
go.drugbank.com/drugs/DB05383InvestigationalPimagedine has been developed by Synvista Therapeutics, Inc for the treatment of diabetic kidney disease.
Isatin
go.drugbank.com/drugs/DB02095ExperimentalIsatin is an indole derivative first obtained by Erdman and Laurent in 1841 as an oxidation product of Indigo dye with nitric acid and chromic acids.
Zaltoprofen
go.drugbank.com/drugs/DB06737InvestigationalA non-steroidal anti-inflammatory drug approved for use in Japan in 1993.
Categories: Analgesics, Non-Narcotic, Non COX-2 selective NSAIDSTasosartan
go.drugbank.com/drugs/DB01349ExperimentalIts long duration of action has been attributed to its active metabolite enoltasosartan. It is used to treat patients with essential hypertension.
Categories: Agents Acting on the Renin-Angiotensin SystemFT516
go.drugbank.com/drugs/DB15732InvestigationalThis compound expresses a high-affinity 158V, CD16 (hnCD16) Fc receptor that has an enhanced binding ability to tumor-targeting antibodies, and is resistant to downregulation. … FT516 is an investigational and engineered off-the-shelf natural killer (NK) cell therapy originating from induced pluripotent stem cells (iPSC).
PRO-542
go.drugbank.com/drugs/DB05793InvestigationalPRO 542 belongs to a new class of drugs, viral-entry inhibitor, which is intended to prevent HIV from entering and infecting cells.
HZT-501
go.drugbank.com/drugs/DB05369InvestigationalHZT-501 is under investigation by Horizon Therapeutics, Inc., a privately held biopharmaceutical company.